Clinical Trials Browser

Diabetes Mellitus, Type 2 × 90 days × Clear all

NCT07513259 2026-04-07

Pre-Diagnosis GLP-1 Receptor Agonist Use and Post-Cancer Mortality in Adults With Obesity and Type 2 Diabetes

203,424 enrolled

Diabetes Mellitus, Type 2, Neoplasms, Obesity, Overweight

NCT06709040 2026-04-06

A Study to Follow Paediatric Participants With Growth Hormone Deficiency Treated With Somapacitan for Long Term Safety Information and Clinical Parameters

Enrolling by invitation

Diabetes Mellitus, Type 2, Dwarfism, Pituitary, Neoplasms

NCT06803771 2026-03-23

SAFE-D

Phase NA Recruiting

15,000 enrolled

Gastrointestinal

Pancreatic cancer, adult, Diabetes Mellitus, Diabetes Mellitus, Type 2, Pancreatic Neoplasms

NCT07296484 2026-03-19

CAPTAIN-T2D

Phase 2 Recruiting

ACTH Syndrome, Ectopic, Cushing Syndrome, Diabetes Mellitus, Type 2

NCT07466212 2026-03-12

QoLIDia

Not yet recruiting

Diabetes Mellitus, Type 2, Neoplasms

NCT07083154 2026-03-05

GLP-1/GCG Dual Agonist in Type 2 Diabetes With Early Dementia (LIGHT-COG Study)

Phase 3 Recruiting

Dementia, Diabetes Mellitus, Type 2, Lymphoma, Follicular, Cognitive Dysfunction

NCT03604198 2026-02-19

Extension Study to Evaluate the Safety of Long-Term Use of Relacorilant in Patients With Cushing Syndrome

Phase 2 Active not recruiting

ACTH Syndrome, Ectopic, Adrenal Cortex Neoplasms, Cushing Syndrome, Diabetes Mellitus, Type 2, Hypertension, Adrenocortical Carcinoma, Pituitary ACTH Hypersecretion

NCT03568630 2026-02-02

Blood Markers of Early Pancreas Cancer

Gastrointestinal

Diabetes Mellitus, Type 2, Pancreatic Cyst, Prediabetic State, Genetic Predisposition to Disease, Genetic Diseases, Inborn, Pancreatitis, Chronic